(Photo Courtesy: www.abcam.com)
The total market size for the medical imaging reagents in India is pegged at US $250-300 million.
In the global arena, India acts as an attractive destination for biopharmaceutical companies across the world, serving as a magnetic place for executing strategic R&D functions.
In such a situation, more and more lab in the country is facing the need for better understanding in molecular pathology and accurate tools for cell analysis.
Mr Ravi Shastri, MD, South Asia, Life Science Solutions, Thermo Fisher Scientific, says that enhanced accuracy of cell imaging and analysis systems helps in reducing the time and costs involved in the drug discovery process.
"This is a major factor driving the growth of the cell analysis market. Furthermore, the market is witnessing significant technological innovations and continuous improvements in cell analysis instruments and consumables for applications such as cell identification, cell proliferation, and target toxicity studies," he commented.